Company Presentation
Oculis Operations Sarl
| Country: | Switzerland |
| Category: | Clinical Stage Biotech Company |
| Room: | Sydney |
| Date: | 23.04.2024. |
| Time: | 15:30 – 15:45 |
| Website: | www.oculis.com |
| Speaker: | Bastian Dehmel, Chief Development Officer |
Company profile
Oculis is a global biopharmaceutical company purposefully driven to save sight and improve eye care. Oculis highly differentiated clinical-stage pipeline includes: OCS-01, a topical candidate in Phase 3 for diabetic macular edema ; OCS-02, a topical biologic candidate in Phase 2b for dry eye disease ; and OCS-05, a disease modifying candidate for acute optic neuritis. Oculis goal is to deliver life-changing eye treatments to patients worldwide.
